At this price, the stock is -62.50% below its 52-week high of $3.04 and 15.15% above its 52-week low of $0.99. Based on the past 30-day period, the stock price is -24.83% below the high and +14.65% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, LAB’s SMA-200 is $1.8272.
As well, it is important to consider LAB stock ratios such as price-to-sales, which is currently 2.48.LAB’s price to book ratio for the most recent quarter was 0.91, resulting in an 1.48 price to cash per share for the period.
How does Standard BioTools Inc (LAB) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.33 in simple terms.
Standard BioTools Inc (LAB): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 2 different analysts, who are expecting earnings to fall in between the range of -0.06 and -0.06 with an average Earnings Estimate of -0.06 which is in contrast with the last year earnings estimate of -0.26 and also replicates 76.92% growth rate year over year.
Standard BioTools Inc (NASDAQ: LAB) Ownership Details
I will give a breakdown of the key shareholders in Standard BioTools Inc (LAB). Recent figures show that the company’s insiders hold 1.86% of shares. A total of 186 institutional investors hold shares in the company, making 73.11% of its stock and 74.49% of its float.
Dec 31, 2024, it was reported that the Company’s largest institutional holder is Casdin Capital, LLC holding total of 71.25 shares that make 18.80% of the company’s total number of shares and are currently priced at 80.87 million.
The securities firm Viking Global Investors, L.P. holds 58.65 shares of LAB, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 15.48%, and the holding percentage of shares is valued at 66.57 million.
An overview of Standard BioTools Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Standard BioTools Inc (LAB) traded 2,334,736 shares per day, with a moving average of $1.1808 and price change of -0.2750. With the moving average of $1.4522 and a price change of -0.6150, about 2,066,506 shares changed hands on average over the past 50 days. Finally, LAB’s 100-day average volume is 2,019,824 shares, alongside a moving average of $1.6602 and a price change of -0.7650.
